International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury-Reference-Cited by-同舟云学术

International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury

Published:1999-01 Issue:1 Volume:10 Page:13-20
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Shipp M.A.,Abeloff M.D.,Antman K.H.,Carroll G.,Hagenbeek A.,Loeffler M.,Montserrat E.,Radford J.A.,Salles G.,Schmitz N.,Symann M.,Armitage J.O.,Coiffier B.,Philip T.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/1/13/19477053/10-1-13.pdf

Reference33 articles.

1. Consensus conference on intensive chemotherapy plus hematopoietic stem cell transplantation in malignancies. Lyon 4–6 June 1993;Coiffier;Ann Oncol,1994

2. Health Care Needs Assessment;Stevens;The Epidemiologically Based Needs Assessment Reviews. Oxford/ New York: Radcliffe Medical Press,1994

3. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma;Philip;N Engl J Med,1995

4. High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin’s lymphoma;Vose;Ann Oncol,1998

5. Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin’s lymphoma: A randomized study from the GELA: LNH RP 93;Bosly;Blood,1997

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas;Leukemia Research;2021-11

2. The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use;The Oncologist;2015-11-30

3. High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era;Leukemia & Lymphoma;2014-03-19

4. SEOM clinical guidelines for the treatment of diffuse large B-cell lymphoma;Clinical and Translational Oncology;2010-11

5. Prognostic value of comorbidity for auto-SCT eligibility and outcome in relapsed or refractory aggressive non-Hodgkin's lymphoma;Bone Marrow Transplantation;2010-08-23